For years, Alzheimer’s disease has been considered a brain disorder that leads to memory loss and cognitive decline. It’s a ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

Aug. 23, 2021 — Amyloid plaques found in the retinas of eyes may be an indicator of similar plaques in the brain, a hallmark of Alzheimer's disease, and may provide a more visible biomarker for ...

Look closely and you'll see brown amyloid beta plaques are visible in the brain tissue sample in the left slide - on the right is brain tissue that had been treated and no longer contains amyloid ...

The condition is “high-risk” plaque, once narrowly defined as plaque built up in the arteries that is likely to rupture, possibly leading to an acute heart attack or sudden cardiac death.

Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and ...

they show that radiolabeled Aβ administered intravenously is capable of crossing the blood–brain barrier (BBB) and labeling at least some of the hallmark neuritic plaques in the brain.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain. The findings ...

Now, a new Northwestern Medicine study suggests a promising alternative: enhancing the brain’s own immune cells to clear these plaques more effectively. The findings could reshape the future of ...